{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,1,5]],"date-time":"2026-01-05T22:15:01Z","timestamp":1767651301773,"version":"3.32.0"},"reference-count":47,"publisher":"Springer Science and Business Media LLC","issue":"5-6","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Inflammopharmacol"],"published-print":{"date-parts":[[2005,1]]},"DOI":"10.1163\/156856005774382788","type":"journal-article","created":{"date-parts":[[2005,10,5]],"date-time":"2005-10-05T20:56:32Z","timestamp":1128545792000},"page":"481-492","source":"Crossref","is-referenced-by-count":13,"title":["Prostanoids as friends, not foes: Further evidence from the interference by cycloxygenase-inhibitory drugs when inducing tolerance to experimental arthritigens in rats"],"prefix":"10.1007","volume":"12","author":[{"given":"Michael W.","family":"Whitehouse","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","reference":[{"key":"77438278_CR1","doi-asserted-by":"crossref","first-page":"1320","DOI":"10.1038\/2241320a0","volume":"224","author":"R. L. Aspinall","year":"1969","unstructured":"Aspinall, R. L. and Cammarata, P. S. (1969). Effect of prostag landin E2 on adjuvant arthritis, Nature 224, 1320\u20131321.","journal-title":"Nature"},{"key":"77438278_CR2","doi-asserted-by":"crossref","first-page":"1029","DOI":"10.4049\/jimmunol.164.2.1029","volume":"164","author":"C. Bandeira-Melo","year":"2000","unstructured":"Bandeira-Melo, C., Serra, M. F., Diaz, B. L., Cordeiro, R. S. B., Silva, P. M. R., Lenzi, H. L., Bakhle, Y. S., Serhan, C. N. and Martins, M. A. (2000). Cyclooxygenase-2-derived prostaglandin E2 and Lipoxin A4 accelerate resolution of allergic edema in Angiostrongylus costaricensis-infected rats: relationship with concurrent eosinophilia, J. Immunol. 164, 1029\u20131036.","journal-title":"J. Immunol."},{"key":"77438278_CR3","doi-asserted-by":"crossref","first-page":"1487","DOI":"10.1016\/S0006-2952(99)00223-3","volume":"58","author":"K. H. Banner","year":"1999","unstructured":"Banner, K. H., Hoult, J. R., Taylor, M. N., Landells, L. J. and Page, C. P. (1999). Possible contribution of prostaglandin E2 to the antiproliferative effect of phosphodiesterase 4 inhibitors in human mononuclear cells, Biochem. Pharmacol. 58, 1487\u20131495.","journal-title":"Biochem. Pharmacol."},{"key":"77438278_CR4","doi-asserted-by":"crossref","first-page":"212","DOI":"10.1136\/ard.37.3.212","volume":"37","author":"I. L. Bonta","year":"1978","unstructured":"Bonta, I. L., Parnham, M. J. and van Vliet, L. (1978). Combination of theophylline and prostaglandin-E1 as inhibitors of the adjuvant-induced arthritis syndrome in rats, Ann. Rheum. Dis. 37, 212\u2013217.","journal-title":"Ann. Rheum. Dis."},{"key":"77438278_CR5","unstructured":"Colville-Nash, P. R. (2004). Professor Derek Willoughby (1930\u20132004). pA 2 Online, E-Journal of the Brit. Pharmacol. Soc. 2,Issue 2."},{"key":"77438278_CR6","doi-asserted-by":"crossref","first-page":"189","DOI":"10.1016\/0952-3278(89)90002-1","volume":"35","author":"A. K. Dutta-Roy","year":"1989","unstructured":"Dutta-Roy, A. K., Kahn, N. N. and Sinha, A. K. (1989). Prostaglandin E1; the endogenous physiological regulator of platelet mediated blood coagulation, Prostaglandins Leukotrienes Essent. Fatty Acids Rev. 35, 189\u2013195.","journal-title":"Prostaglandins Leukotrienes Essent. Fatty Acids Rev."},{"key":"77438278_CR7","doi-asserted-by":"crossref","first-page":"153","DOI":"10.1016\/S0065-2776(08)60787-7","volume":"73","author":"A. Faria","year":"1999","unstructured":"Faria, A. and Weiner, H. L. (1999). Oral tolerance: mechanisms and therapeutic application, Adv. Immunol. 73, 153\u2013264.","journal-title":"Adv. Immunol."},{"key":"77438278_CR8","doi-asserted-by":"crossref","first-page":"698","DOI":"10.1038\/9550","volume":"5","author":"D. W. Gilroy","year":"1999","unstructured":"Gilroy, D. W., Colville-Nash, P. R., Willis, D., Chivers, J., Paul-Clark, M. J. and Willoughby, D. A. (1999). Inducible cyclooxygenase may have anti-inflammatory properties. Nature Med. 5, 698\u2013701.","journal-title":"Nature Med."},{"key":"77438278_CR9","doi-asserted-by":"crossref","first-page":"2269","DOI":"10.1096\/fj.02-1162fje","volume":"17","author":"D. W. Gilroy","year":"2003","unstructured":"Gilroy, D. W., Colville-Nash, P. R., McMaster, S., Sawatzky, D. A., Willoughby, D.A. and Lawrence, T. (2003). Inducible cyclooxygenase-derived 15-deoxy (Delta)12-14PGJ2 brings about acute inflammatory resolution in rat pleurisy by inducing neutrophil and macrophage apoptosis, FASEB J. 17, 2269\u20132271.","journal-title":"FASEB J."},{"key":"77438278_CR10","first-page":"1133","volume-title":"Inflammation Basic Principles and Clinical Correlates","author":"I. M. Goldstein","year":"1992","unstructured":"Goldstein, I. M. (1992). Anti-inflammatory effects of prostaglandins, in: Inflammation Basic Principles and Clinical Correlates, 2nd edn, Gallin, H. I., Goldstein, I. M. and Snyderman, R. (Eds.), pp. 1133\u20131137. Raven Press, New York, NY.","edition":"2nd edn"},{"key":"77438278_CR11","first-page":"284","volume":"32","author":"B. Guas","year":"2000","unstructured":"Guas, B. (2000). Lyprinol inhibits LTB4 production by human monocytes, Allerg. Immunol. (Paris) 32, 284\u2013289.","journal-title":"Allerg. Immunol. (Paris)"},{"key":"77438278_CR12","volume-title":"Lyprinol, A natural solution for arthritis and other inflammatory disorders","author":"G. Halpern","year":"2001","unstructured":"Halpern, G. (2001). Lyprinol, A natural solution for arthritis and other inflammatory disorders. Avery, New York, NY."},{"key":"77438278_CR13","doi-asserted-by":"crossref","first-page":"620","DOI":"10.1136\/ard.47.8.620","volume":"47","author":"A. E. K. Henriksson","year":"1988","unstructured":"Henriksson, A. E. K., Tagesson, C., Uribe, A., Uvnas-Moberg, K., Nord, C.-E., Gullberg, R. and Johansson, D. (1988). Effects of prostaglandin E2 on disease activity, gastric secretion and intestinal permeability, and morphology in patients with rheumatoid arthritis, Ann. Rheum. Dis. 47, 620\u2013627.","journal-title":"Ann. Rheum. Dis."},{"key":"77438278_CR14","first-page":"471","volume":"100","author":"D. F. Horrobin","year":"1988","unstructured":"Horrobin, D. F. (1988). Prostaglandin E1: physiological significance and clinical use, Wiener Clin. Wochenschr. 100, 471\u2013477.","journal-title":"Wiener Clin. Wochenschr."},{"key":"77438278_CR15","doi-asserted-by":"crossref","first-page":"6","DOI":"10.1111\/j.1476-5381.1978.tb08633.x","volume":"64","author":"J. R. Hoult","year":"1978","unstructured":"Hoult, J. R. and Moore, P. K. (1978). Sulphasalazine is a potent inhibitor of prostaglandin 15-hydroxydehydrogenase: possible basis for therapeutic action in ulcerative colitis, Br. J. Phamacol. 64, 6\u20138.","journal-title":"Br. J. Phamacol."},{"key":"77438278_CR16","doi-asserted-by":"crossref","first-page":"255","DOI":"10.1016\/S0140-6736(81)90502-X","volume":"ii","author":"J. R. Hoult","year":"1981","unstructured":"Hoult, J. R. and Page, H. (1981). 5-Aminosalicylic acid, a co-factor for colonic prostacyclin synthesis?, Lancet ii, 255.","journal-title":"Lancet"},{"key":"77438278_CR17","first-page":"1461","volume":"18","author":"E. A. Kitsis","year":"1991","unstructured":"Kitsis, E. A., Weissmann, G. and Abramson, S. B. (1991). The prostaglandin paradox: additive inhibition of neutrophil function by aspirin-like drugs and the prostaglandin E1 analogue Misoprostol, J. Rheumatol. 18, 1461\u20131465.","journal-title":"J. Rheumatol."},{"key":"77438278_CR18","doi-asserted-by":"crossref","first-page":"1197","DOI":"10.1136\/ard.2003.011163","volume":"63","author":"R. Largo","year":"2004","unstructured":"Largo, R., Diez-Ortego, I., Sanchez-Pernaute, O., Lopez-Armada, M. J., Alvarez-Soria, M. A., Egido, J. and Herrero-Beaumont, G. (2004). EP2\/EP4 signalling inhibits monocyte chemoattractant protein-1 production induced by interleukin-1\u03b2 in synovial fibroblasts, Ann. Rheum. Dis. 63, 1197\u20131204.","journal-title":"Ann. Rheum. Dis."},{"key":"77438278_CR19","doi-asserted-by":"crossref","first-page":"1291","DOI":"10.1038\/nm1201-1291","volume":"7","author":"T. Lawrence","year":"2001","unstructured":"Lawrence, T., Gilroy, D. W., Colville-Nash, P. R. and Willoughby, D. A. (2001). Possible new role for NF-kappaB in the resolution of inflammation, Nature Med. 7, 1291\u20131297.","journal-title":"Nature Med."},{"key":"77438278_CR20","doi-asserted-by":"crossref","first-page":"787","DOI":"10.1038\/nri915","volume":"2","author":"T. Lawrence","year":"2002","unstructured":"Lawrence, T., Willoughby, D. A. and Gilroy, D. W. (2002). Anti-inflammatory lipid mediators and insights into the resolution of inflammation, Nature Rev. Immunol. 2, 787\u2013795.","journal-title":"Nature Rev. Immunol."},{"key":"77438278_CR21","doi-asserted-by":"crossref","first-page":"439","DOI":"10.1007\/s00011-003-1213-5","volume":"52","author":"A. J. Lewis","year":"2003","unstructured":"Lewis, A. J. (2003). Inflammation research lifetime achievement award 2003, presented to Derek A. Willoughby, Inflamm. Res. 52, 439\u2013440.","journal-title":"Inflamm. Res."},{"key":"77438278_CR22","doi-asserted-by":"crossref","first-page":"301","DOI":"10.1126\/science.1071059","volume":"296","author":"P. Matzinger","year":"2002","unstructured":"Matzinger, P. (2002). The danger model: a renewed sense of self, Science 296, 301\u2013305.","journal-title":"Science"},{"key":"77438278_CR23","doi-asserted-by":"crossref","first-page":"1204","DOI":"10.1002\/1529-0131(199906)42:6<1204::AID-ANR17>3.0.CO;2-U","volume":"42","author":"K. M. McKown","year":"1999","unstructured":"McKown, K. M., Carbone, L. D., Kaplan, S. B., Aelion, J. A., Lohr, K. M., Cremer, M. A., Bustillo, J., Gonzalez, M., Kaeley, G., Steere, E. L., Somes, G. W., Myers, L. K., Seyer, J. M., Kang, A. H. and Postlethwaite, A. E. (1999). Lack of efficacy of oral bovine type II collagen added to existing therapy in rheumatoid arthritis, Arthritis Rheum. 42, 1204\u20131208.","journal-title":"Arthritis Rheum."},{"key":"77438278_CR24","doi-asserted-by":"crossref","first-page":"969","DOI":"10.1016\/0006-2952(82)90329-X","volume":"31","author":"P. K. Moore","year":"1982","unstructured":"Moore, P. K. and Hoult, J. R. (1982). Selective actions of aspirin-and sulphasalazine-like drugs against prostaglandin synthesis and breakdown, Biochem. Pharmacol. 31, 969\u2013971.","journal-title":"Biochem. Pharmacol."},{"key":"77438278_CR25","first-page":"105","volume":"45","author":"A. M. Mowat","year":"1982","unstructured":"Mowat, A. M., Strobel, S., Drummond, A. G. and Ferguson, A. (1982). Immunological responses to fed protein antigens in mice. I. Reversal of oral tolerance to ovalbumin by cyclophosphamide, Immunology 45, 105\u2013113.","journal-title":"Immunology"},{"key":"77438278_CR26","doi-asserted-by":"crossref","first-page":"135","DOI":"10.1111\/j.1600-065X.1990.tb00571.x","volume":"117","author":"R. P. Phipps","year":"1990","unstructured":"Phipps, R. P., Roper, R. L. and Stein, S. H. (1990). Regulation of B cell tolerance and triggering by macrophages and lymphoid dendritic cells, Immunol. Rev. 117, 135\u2013158.","journal-title":"Immunol. Rev."},{"key":"77438278_CR27","doi-asserted-by":"crossref","first-page":"349","DOI":"10.1016\/0167-5699(91)90064-Z","volume":"12","author":"R. P. Phipps","year":"1991","unstructured":"Phipps, R. P., Stein, S. H. and Roper, R. L. (1991). A new view of prostaglandin E regulation of the immune system, Immunol. Today 12, 349\u2013352.","journal-title":"Immunol. Today"},{"key":"77438278_CR28","doi-asserted-by":"crossref","first-page":"407","DOI":"10.1163\/156856005774382779","volume":"12","author":"K. D. Rainsford","year":"2005","unstructured":"Rainsford, K. D. (2005). Professor Derek Albert Willoughby (1930\u20132004), Inflammopharmacology 12, 407\u2013439.","journal-title":"Inflammopharmacology"},{"key":"77438278_CR29","doi-asserted-by":"crossref","first-page":"49","DOI":"10.1007\/BF02659110","volume":"3","author":"K. D. Rainsford","year":"1995","unstructured":"Rainsford, K. D., Whitehouse, M. W. and Vernon-Roberts, B. (1995). Effects of prostaglandin E1, Misoprostol, on the development of adjuvant arthritis in rats, Inflammopharmacology 3, 49\u201363.","journal-title":"Inflammopharmacology"},{"key":"77438278_CR30","doi-asserted-by":"crossref","first-page":"108","DOI":"10.1007\/BF02022990","volume":"28","author":"J. Raud","year":"1989","unstructured":"Raud, J., Sydbom, A., Dahlen, S.-E. and Hedqvist, P. (1989). Prostaglandin E2 prevents diclofenac-induced enhancement of histamine release and inflammation invoked by in vivo challenge with compound 48\/80 in the hamster cheek pouch, Agents Actions 28, 108\u2013114.","journal-title":"Agents Actions"},{"key":"77438278_CR31","doi-asserted-by":"crossref","first-page":"409","DOI":"10.1016\/0008-8749(87)90042-6","volume":"104","author":"W. V. Scheuer","year":"1987","unstructured":"Scheuer, W. V., Hobbs, M. V. and Weigle, W. O. (1987). Interference with tolerance induction in vivo by inhibitors of prostaglandin synthesis, Cell Immunol. 104, 409\u2013418.","journal-title":"Cell Immunol."},{"key":"77438278_CR32","doi-asserted-by":"crossref","first-page":"1481","DOI":"10.1172\/JCI13375","volume":"107","author":"C. N. Serhan","year":"2001","unstructured":"Serhan, C. N. and Oliw, E. (2001). Unorthodox routes to prostaglandin formation: new twists in cyclooxygenase pathways, J. Clin. Invest. 107, 1481\u20131489.","journal-title":"J. Clin. Invest."},{"key":"77438278_CR33","doi-asserted-by":"crossref","first-page":"1383","DOI":"10.1016\/S0022-3565(24)37734-1","volume":"286","author":"J.-I. Shigata","year":"1998","unstructured":"Shigata, J.-I., Takahashi, S. and Okave, S. (1998). Role of COX-2 in the healing of gastric ulcers in rats, J. Pharmacol. Exp. Ther. 286, 1383\u20131390.","journal-title":"J. Pharmacol. Exp. Ther."},{"key":"77438278_CR34","doi-asserted-by":"crossref","first-page":"271","DOI":"10.1002\/path.1700800210","volume":"80","author":"W. G. Spector","year":"1960","unstructured":"Spector, W. G. and Willoughby, D. A. (1960). The enzymic inactivation of an adrenalin-like substance in inflammation, J. Pathol. Bacteriol. 80, 271\u2013280.","journal-title":"J. Pathol. Bacteriol."},{"key":"77438278_CR35","doi-asserted-by":"crossref","first-page":"396","DOI":"10.1016\/0167-5699(90)90158-6","volume":"11","author":"S. H. G. Thompson","year":"1990","unstructured":"Thompson, S. H. G. and Staines, N. A. (1990). Could specific oral tolerance be a therapy for autoimmune disease?, Immunol. Today 11, 396\u2013399.","journal-title":"Immunol. Today"},{"key":"77438278_CR36","doi-asserted-by":"crossref","first-page":"609","DOI":"10.1126\/science.6573024","volume":"220","author":"M. J. Tyler","year":"1983","unstructured":"Tyler, M. J., Shearman, D. J., Franco, R., O\u2019Brien, P., Seamark, R. F. and Kelly, R. (1983). Inhibition of gastric acid secretion in the gastric brooding frog Rheobatrachus silus, Science 220, 609\u2013610.","journal-title":"Science"},{"key":"77438278_CR37","first-page":"275","volume":"6","author":"G. Weissmann","year":"1993","unstructured":"Weissmann, G. (1993). Prostaglandins as modulators rather than mediators of inflammation, J. Lipid Mediat. 6, 275\u2013286.","journal-title":"J. Lipid Mediat."},{"issue":"Suppl.","key":"77438278_CR38","first-page":"A104","volume":"34","author":"M. W. Whitehouse","year":"2004","unstructured":"Whitehouse, M. W. (2004). Smoking & Arthritis: thiocyanate (from HCN in smoke) ruptures tolerance to experimental arthritigens in rats, Intern. Med. J. 34(Suppl.), A104.","journal-title":"Intern. Med. J."},{"key":"77438278_CR39","unstructured":"Whitehouse, M. W. and Vernon-Roberts, B. (1989). Prevention of rat polyarthritis induced with mycobacterial or avridine adjuvants, Abstr. XVII th. ILAR Congr. Rheumatol. Rio de Janeiro, Brazil."},{"key":"77438278_CR40","doi-asserted-by":"crossref","first-page":"61","DOI":"10.1007\/BF02735462","volume":"1","author":"M. W. Whitehouse","year":"1991","unstructured":"Whitehouse, M. W. and Vernon-Roberts, B. (1991). Conditional pharmacology: expression of anti-inflammatory activity may require pre-existent inflammatory mediators and\/or hormones, Inflammopharmacology 1, 61\u201368.","journal-title":"Inflammopharmacology"},{"key":"77438278_CR41","doi-asserted-by":"crossref","first-page":"237","DOI":"10.1007\/s10787-997-0002-0","volume":"5","author":"M. W. Whitehouse","year":"1997","unstructured":"Whitehouse, M. W., Macrides, T. A., Kalafatis, N., Betts, W. H., Haynes, D. R. and Broadbent, J. (1997). Anti-inflammatory activity of a lipid fraction (Lyprinol\u00ae) from the New Zealand green-lipped mussel, Inflammopharmacology 5, 237\u2013246.","journal-title":"Inflammopharmacology"},{"key":"77438278_CR42","doi-asserted-by":"crossref","first-page":"87","DOI":"10.1038\/nm0196-87","volume":"2","author":"D. Willis","year":"1996","unstructured":"Willis, D., Moore, A. R., Frederick, R. and Willoughby, D. A. (1996). Heme oxygenase: a novel target for the modulation of the inflammatory response, Nature Med. 2, 87\u201390.","journal-title":"Nature Med."},{"key":"77438278_CR43","doi-asserted-by":"crossref","first-page":"627","DOI":"10.1002\/(SICI)1096-9896(200004)190:5<627::AID-PATH556>3.0.CO;2-2","volume":"190","author":"D. Willis","year":"2000","unstructured":"Willis, D., Moore, A. R. and Willoughby, D. A. (2000). Heme oxygenase isoform expression in cellular and antibody-mediated models of acute inflammation in the rat, J. Pathol. 190, 627\u2013634.","journal-title":"J. Pathol."},{"key":"77438278_CR44","doi-asserted-by":"crossref","first-page":"381","DOI":"10.1002\/path.1700960216","volume":"96","author":"D. A. Willoughby","year":"1968","unstructured":"Willoughby, D. A. (1968). Effects of PGF2\u03b1 and PGE1 on vascular permeability, J. Pathol. Bacteriol. 96, 381\u2013387.","journal-title":"J. Pathol. Bacteriol."},{"key":"77438278_CR45","doi-asserted-by":"crossref","first-page":"1131","DOI":"10.1016\/S0192-0561(00)00064-3","volume":"22","author":"D. A. Willoughby","year":"2000","unstructured":"Willoughby, D. A., Moore, A. R., Colville-Nash, P. R. and Gilroy, D. (2000a). Resolution of inflammation, Int. J. Immunopharmacol. 22, 1131\u20131135.","journal-title":"Int. J. Immunopharmacol."},{"key":"77438278_CR46","doi-asserted-by":"crossref","first-page":"137","DOI":"10.1038\/72224","volume":"6","author":"D. A. Willoughby","year":"2000","unstructured":"Willoughby, D. A., Moore, A. R. and Colville-Nash, P. R. (2000b). Cyclopentenone prostaglandins \u2014 new allies in the war on inflammation, Nature Med. 6, 137\u2013138.","journal-title":"Nature Med."},{"key":"77438278_CR47","doi-asserted-by":"crossref","first-page":"304","DOI":"10.1038\/234304a0","volume":"234","author":"R. B. Zurier","year":"1971","unstructured":"Zurier, R. B. and Quagliatta, F. (1971). Effect of prostanglandin E1 on adjuvant arthritis, Nature 234, 304\u2013305.","journal-title":"Nature"}],"container-title":["InflammoPharmacology"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/www.springerlink.com\/index\/pdf\/10.1163\/156856005774382788","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,1,4]],"date-time":"2025-01-04T18:53:29Z","timestamp":1736016809000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1163\/156856005774382788"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2005,1]]},"references-count":47,"journal-issue":{"issue":"5-6","published-print":{"date-parts":[[2005,1]]}},"alternative-id":["77438278"],"URL":"https:\/\/doi.org\/10.1163\/156856005774382788","relation":{},"ISSN":["0925-4692","1568-5608"],"issn-type":[{"type":"print","value":"0925-4692"},{"type":"electronic","value":"1568-5608"}],"subject":[],"published":{"date-parts":[[2005,1]]}}}